Endocrine Reviews

Papers
(The H4-Index of Endocrine Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway634
Papillary Craniopharyngioma: An Integrative and Comprehensive Review298
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”230
DNA Damage and Repair in Thyroid Physiology and Disease226
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies213
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future185
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases171
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes128
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention128
The Molecular Biology of Midgut Neuroendocrine Neoplasms124
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity115
Effects of Maternal Vitamin D Supplementation on Childhood Health115
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story113
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”108
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies91
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment88
Calcium-sensing receptor regulation of gastrointestinal hormone secretion87
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?83
The Biology and Clinical Implications of PCSK776
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors71
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism69
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status68
Estrogen Receptor Signaling in the Immune System67
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature66
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas63
Contemporary Biological Insights and Clinical Management of Craniopharyngioma63
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”62
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review60
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction57
The Metabolic Role and Therapeutic Potential of the Microbiome56
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance55
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia53
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling51
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases50
The Cortisol Awakening Response: Regulation and Functional Significance50
Imaging of Pheochromocytomas and Paragangliomas48
Adiponectin and Adiponectin Receptors in Atherosclerosis47
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease46
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood45
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease45
Molecular and Clinical Spectrum of Primary Hyperparathyroidism44
Brown Adipose Tissue—A Translational Perspective44
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications44
Endocrine Controls of Skin Aging43
0.3592700958252